SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
7.83
+0.08 (1.03%)
Jun 12, 2026, 1:45 PM EDT - Market open
SLS Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SLS stock have an average target of $10, which predicts a 27.71% increase from the current stock price of 7.83.
Price Target: $10 (+27.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SLS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $10 | Buy | Reiterates | $10 | +27.71% | May 14, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $10 | Buy | Reiterates | $10 | +27.71% | May 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
44.25M
EPS This Year
-0.21
from -0.25
EPS Next Year
-0.15
from -0.21
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | ||
| Avg | n/a | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.21 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |